Literature DB >> 6372675

Recent advances in 21-hydroxylase deficiency.

M I New, L S Levine.   

Abstract

A deficiency of 21-hydroxylase in the adrenal cortex results in insufficient cortisol production. The salt-wasting form of 21-hydroxylase deficiency is characterized by inadequate aldosterone production, as well. Because the hypothalamic-adrenal negative feedback system is broken, excess adrenal androgens are produced. This disordered corticosteroid production causes hormonal and clinical symptoms, including pseudohermaphroditism in genetic females and disordered puberty in both males and females. There is a spectrum of the time of onset and the severity of these symptoms. This disorder is inherited in an autosomal recessive manner. The 21-hydroxylase deficiency is genetically linked to the human leukocyte antigen (HLA) complex; in addition, nonclassical and classical 21-hydroxylase deficiency have each been shown to be in genetic linkage disequilibrium with specific HLA-B antigens. This genetic linkage, used in conjunction with baseline and stimulated serum hormonal levels, is useful in the diagnosis of this disorder. Prenatal diagnosis of homozygote, heterozygote, and unaffected fetuses is also available. Adequate treatment with glucocorticoid and mineralocorticoid replacement resolves symptoms and enables a normal life.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372675     DOI: 10.1146/annurev.me.35.020184.003245

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  12 in total

1.  HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.

Authors:  F Parlato; G Pisano; G Misiano; E Cosentini; C Cacciapuoti; M R Cavalcanti; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

2.  Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency.

Authors:  Y Higashi; A Tanae; H Inoue; Y Fujii-Kuriyama
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Gender verification in sport: the need for change?

Authors:  M A Ferguson-Smith; E A Ferris
Journal:  Br J Sports Med       Date:  1991-03       Impact factor: 13.800

4.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

5.  A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency.

Authors:  S L Sherman; C E Aston; N E Morton; P W Speiser; M I New
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

6.  Genetic mapping of the 21-hydroxylase locus: estimation of small recombination frequencies.

Authors:  C E Aston; S L Sherman; N E Morton; P W Speiser; M I New
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

7.  Evolutionary origin of mutations in the primate cytochrome P450c21 gene.

Authors:  H Kawaguchi; C O'hUigin; J Klein
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

8.  Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products.

Authors:  Y Higashi; A Tanae; H Inoue; T Hiromasa; Y Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia.

Authors:  G Rumsby; M C Carroll; R R Porter; D B Grant; M Hjelm
Journal:  J Med Genet       Date:  1986-06       Impact factor: 6.318

10.  Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia.

Authors:  H H Lee; H T Chao; H T Ng; K B Choo
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.